Trade PACB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Pacific Biosciences of California, Inc. (PACB) is trading at US$1.37, down 0.72% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$419.62M. Over the past 52 weeks, PACB has traded between US$1.07 and US$2.73. On Syfe you can trade PACB with $0 commission and add it to your watchlist.
| Previous close | US$1.38 |
|---|---|
| Market cap | US$419.62M |
| 52-week range | US$1.07 – US$2.73 |
| Volume | 4.91M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Year: 2010
Pacific Biosciences of California, Inc. (PACB) stock is trading at US$1.37, -0.72% from the previous close of US$1.38.
The market cap for Pacific Biosciences of California, Inc. (PACB) stock is approximately US$419.62M.
The 52-week high for Pacific Biosciences of California, Inc. (PACB) stock is US$2.73.
The 52-week low for Pacific Biosciences of California, Inc. (PACB) stock is US$1.07.
Pacific Biosciences of California, Inc. (PACB) does not currently pay a dividend.
Stay on top of PACB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
